Lydian Cosmetic Surgery Clinic Introduces Stem Cell Skin Treatment in Dongdaemun

Lydian Cosmetic Surgery Clinic has introduced stem cell skin treatment in Dongdaemun, Seoul, bringing regenerative, non-surgical aesthetic options to patients as global interest in collagen-supporting therapies and skin rejuvenation continues to grow.

Seoul, Korea, Republic of, August 3, 2026 -- Lydian Cosmetic Surgery Clinic has announced the availability of stem cell skin treatment services in Dongdaemun, Seoul, as growing interest in regenerative aesthetics continues to drive research into non-surgical approaches for skin rejuvenation. The clinic offers regenerative treatment options that support collagen production and improve skin quality using autologous stem cell therapy and exosome-based regenerative techniques.

More information is available at https://www.lydianclinic.com/stemcelleng/skin-rejuvenation-koreas-secret-to-youthful-skin/

South Korea continues to strengthen its position as a global destination for regenerative aesthetics and medical tourism. According to South Korea's Ministry of Health and Welfare, 2.01 million international patients visited the country in 2025, the first time annual medical visitors have surpassed two million, with cosmetic and dermatology services among the most sought-after specialties. The growing international demand reflects South Korea's reputation for advanced medical infrastructure, physician expertise, and innovative aesthetic treatments.

Lydian Clinic explains that their regenerative skin treatments are tailored to individual patient needs and may include autologous stem cell therapy or exosome-based regenerative techniques. These approaches support the skin's natural repair processes by encouraging collagen and elastin production, with the goal of improving skin texture, elasticity and overall skin quality. As with any medical treatment, results vary depending on individual factors including skin condition, age and treatment plan.

"Regenerative medicine continues to expand the range of non-surgical options available in aesthetic care," said Dr. Abraham An, the founder of the clinic. "As clinical research advances, we're gaining a better understanding of how cell-based therapies may contribute to skin regeneration and healthy ageing while allowing treatments to be tailored to each patient's individual needs."

Stem cell therapy is changing how doctors approach skin rejuvenation. As research continues, regenerative treatments are giving patients more non-surgical options while helping doctors better understand how to support the skin's natural repair processes.

About Lydian Cosmetic Surgery Clinic

Lydian Cosmetic Surgery Clinic is a Seoul-based medical centre specialising in regenerative medicine, stem cell therapy and cosmetic surgery. Led by Dr. Abraham An, the clinic provides treatment programs across orthopaedic, neurological, autoimmune and aesthetic fields and operates under designation from South Korea's Ministry of Health and Welfare as an Advanced Regenerative Medicine Implementing Institution.

Additional information can be found at https://www.lydianclinic.com/

Contact Info:
Name: Dr. Abraham An
Email: Send Email
Organization: Lydian Cosmetic Surgery Clinic
Address: 836 Nonhyeon-ro, Sinsa-dong, Gangnam, Seoul, Seoul 06025, Korea, Republic of
Website: https://www.lydianclinic.com/

Release ID: 89199655

Should any errors, concerns, or inconsistencies arise from the content provided in this press release that require attention or if a press release needs to be taken down, we kindly request that you immediately contact us at [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our efficient team will be at your disposal for timely assistance within 8 hours – taking necessary measures to rectify identified issues or providing guidance on the removal process. We prioritize delivering accurate and reliable information.

You May Also Be Interested In

• Mr. Ghyslain Rivard Files an Early Warning Report
• Capital Southwest Increases Corporate Credit Facility to $595 million and Extends Maturity to September 2031
• Freedom Gold Corp. Announces Appointment of CEO and Flow-Through Private Placement